Patient and clinical factors associated with response to medications for posttraumatic stress disorder - Shiner BR, Gui J, Rozema L, Cornelius SL, Dufort V, Schnurr PP, Watts BV.
OBJECTIVE: Fluoxetine, paroxetine, sertraline, topiramate, and venlafaxine have previously shown efficacy for posttraumatic stress disorder (PTSD) in randomized clinical trials. Two prior studies using Department of Veterans Affairs (VA) medical records da... (Source: SafetyLit)
Source: SafetyLit - October 11, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Sarafem (Fluoxetine Hydrochloride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 4, 2021 Category: Drugs & Pharmacology Source Type: news

Years of Prozac Alter Lipids in Young Monkeys ’ Brains: Study
Long-term administration of the antidepressant fluoxetine was tied to decreased concentrations of about 100 different brain lipids in adolescent macaques, hinting at a potential mechanism underlying... (Source: The Scientist)
Source: The Scientist - September 10, 2021 Category: Science Tags: News & Opinion Source Type: news

Final Word on SSRI for Post-Stroke Depression? Final Word on SSRI for Post-Stroke Depression?
The antidepressant fluoxetine does not prevent or alleviate post-stroke depression, new findings from a randomized, placebo-controlled trial confirm.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 12, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Prenatal exposure to THC, CBD affects offspring's responsiveness to fluoxetine
(Indiana University) Scientists have found that significant amounts of the two main components of cannabis, THC and CBD, enter the embryonic brain of mice in utero and impair the mice's ability as adults to respond to fluoxetine, a drug commonly known by the brand name Prozac. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 1, 2021 Category: International Medicine & Public Health Source Type: news

Dash Xclusive Issues Voluntary Nationwide Recall of Imperia Elita Vitaccino Coffee Due to the Presence of Undeclared Sibutramine and Fluoxetine
Dash Xclusive is voluntarily recalling all lots of Imperia Elita Vitaccino Coffee to the consumer level. FDA analysis has found the product to contain undeclared sibutramine and fluoxetine. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 28, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Author Q & A: New generation antidepressants for depression in children and adolescents
In this author interview we find out more about this recently published Network Meta-analysis,New generation antidepressants for depression in children and adolescents. Authors Dr. Sarah Hetrick and Nick Meader tell us about this work.What were you trying to find out with this Network Meta-Analysis?We were trying to find out how well newer generation antidepressants work compared with placebo and if some are more effective than others. We wanted to know how these antidepressants affect:symptoms of depression;recovery: no longer meeting diagnostic criteria for major depressive disorder;response or remission: scores on a sca...
Source: Cochrane News and Events - May 11, 2021 Category: Information Technology Authors: Rachel Klabunde Source Type: news

Trajectories of change in depression symptoms and suicidal ideation over the course of evidence-based treatment for depression: secondary analysis of a randomised controlled trial of cognitive behavioural therapy plus fluoxetine in young people - Witt K, Madsen T, Berk M, Dean O, Chanen A, McGorry PD, Cotton S, Davey CG, Hetrick S.
OBJECTIVES: Effective treatment of depression is a key target for suicide prevention strategies. However, only around one-third of young people with suicide risk respond to evidence-based treatments. Understanding the trajectory of suicidal ideation, as a ... (Source: SafetyLit)
Source: SafetyLit - March 19, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Popular antidepressant is turning fish into "zombies," new research shows
(Natural News) Fluoxetine, a popular antidepressant sold under the brand name Prozac, might soon need a new warning label – “Caution: This antidepressant turns fish into zombies.” Findings of a new study showed that long-term exposure to fluoxetine made guppies act more alike, erasing crucial behavioral differences. Giovanni Polverino, a behavioral ecologist from the University of Western Australia, led the the... (Source: NaturalNews.com)
Source: NaturalNews.com - February 14, 2021 Category: Consumer Health News Source Type: news

Serious Shortage Protocols for fluoxetine 30mg capsules and Salazopyrin EN-Tabs 500mg
The Department of Health and Social Care (DHSC) has issued Serious Shortage Protocols (SSP) for fluoxetine 30mg capsules and Salazopyrin® EN-Tabs 500mg. The fluoxetine 30mg capsules SSP will ena (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 21, 2020 Category: Drugs & Pharmacology Source Type: news

Update – Fluoxetine 40mg capsule Serious Shortage Protocol extension
The Department of Health& Social Care (DHSC) has informed us of an extensionto the following Serious Shortage Protocol (SSP). Fluoxetine 40mg capsules The SSP for fluoxetine 40mg capsules is bein (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 25, 2020 Category: Drugs & Pharmacology Source Type: news

Update – Fluoxetine Serious Shortage Protocol extensions
The Department of Health& Social Care (DHSC) has informed us of extensions to the following Serious Shortage Protocols (SSPs). Fluoxetine 40mg capsules The SSP for fluoxetine 40mg capsules is be (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 3, 2020 Category: Drugs & Pharmacology Source Type: news

Effective treatment and prevention of attempted suicide, anxiety and aggressiveness with fluoxetine, despite proven use of androgenic anabolic steroids - Amaral JMX, Padilha MC, Chagas SV, Baker JS, Mullen C, Vieira Neto L, Aquino Neto FR, Cruz MS.
This report includes 30 days of inpatient treatment and a 6-month follow-up. R... (Source: SafetyLit)
Source: SafetyLit - August 21, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Serious shortage protocol (SSP) for fluoxetine - extension
The Department of Health and Social Care (DHSC) issued a Serious Shortage Protocols (SSP) for fluoxetine 40mg capsules. This has been extended to Friday 4 September. Further information on the SSP ca (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 11, 2020 Category: Drugs & Pharmacology Source Type: news

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial - AFFINITY Trial Collaboration.
BACKGROUND: Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethni... (Source: SafetyLit)
Source: SafetyLit - July 27, 2020 Category: International Medicine & Public Health Tags: Falls Source Type: news

Serious shortage protocol (SSP) for fluoxetine - extension
The Department of Health and Social Care (DHSC) issued a Serious Shortage Protocols (SSP) for fluoxetine 40mg capsules. This has been extended to Monday 10 August Further information on the SSP can b (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 16, 2020 Category: Drugs & Pharmacology Source Type: news

Serious shortage protocol (SSP) for fluoxetine (England) - extension
The Department of Health and Social Care (DHSC) issued a Serious Shortage Protocols (SSP) for fluoxetine 10mg tablets. This has been extended to Friday 11 September 2020. Further information on the S (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 2, 2020 Category: Drugs & Pharmacology Source Type: news

Behavioral therapy and fluoxetine treatment in aggressive dogs: a case study - Odore R, Rendini D, Badino P, Gardini G, Cagnotti G, Meucci V, Intorre L, Bellino C, D'Angelo A.
Canine aggression is a major concern, affecting millions of people worldwide, and treatment can be challenging even for skilled veterinarians. Empiric use of fluoxetine is sometimes attempted, although few data regarding long-term effects in aggressive dog... (Source: SafetyLit)
Source: SafetyLit - May 18, 2020 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Fluoxetine Disappoints in Two New Stroke Trials Fluoxetine Disappoints in Two New Stroke Trials
The antidepressant failed to yield improvements in stroke recovery and was associated with an increase in fracture rates in the EFFECTS and AFFINITY studies.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - May 14, 2020 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news

Aurobindo Pharma gets USFDA nod for generic antidepressant tablets
The company has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine tablets in the strengths of 10 mg and 20 mg, Aurobindo Pharma said in a filing to BSE. The tablets are generic version of Eli Lilly's Prozac tablets, it added. The product will be launched in April 2020. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 8, 2020 Category: Pharmaceuticals Source Type: news

Serious shortage protocol (SSP) for Fluoxetine (England)
The Department of Health and Social Care (DHSC) have decided to issue a Serious Shortage Protocols (SSP)... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 12, 2020 Category: Drugs & Pharmacology Source Type: news

Podcast: Selective serotonin reuptake inhibitors for stroke recovery
Stroke is a major cause of death and disability across the world, with many reviews from the Cochrane Stroke Group providing evidence on the effects of treatments and rehabilitation interventions. In November 2019, the Group published their update of their review of selective serotonin reuptake inhibitors and we asked lead author, Gillian Mead from the University of Edinburgh in Scotland, to tell us more.Stroke is a common cause of disability in the community. Although there have been major advances in the care of stroke patients over the last few years, many survivors are still left with physical disability, such as weakn...
Source: Cochrane News and Events - February 26, 2020 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Increased circulatory IL-6 during 8-week fluoxetine treatment is a risk factor for suicidal behaviors in youth - Amitai M, Taler M, Ben-Baruch R, Lebow M, Rotkopf R, Apter A, Fennig S, Weizman A, Chen A.
OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are commonly used to treat anxiety and/or depression in pediatric populations. However, the response rates are low (approximately 50%). Moreover, SSRI use is frequently associated with adverse even... (Source: SafetyLit)
Source: SafetyLit - January 1, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Using antidepressants while pregnant can increase the risk of autism in newborns – study
(Natural News) Pregnant women can add antidepressants to their laundry list of things to avoid during pregnancy. The results of a recent study revealed that babies exposed to the pharmaceutical drug fluoxetine in the womb could develop autistic-like behavior later on. The study, published in the journal Molecular Brain, also identified a potential therapy for the problem,... (Source: NaturalNews.com)
Source: NaturalNews.com - December 3, 2019 Category: Consumer Health News Source Type: news

Amendments to Serious Shortage Protocols for fluoxetine 30mg capsules (England)
The Serious Shortage Protocols (SSP) for fluoxetine 30mg capsules has been varied... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 20, 2019 Category: Drugs & Pharmacology Source Type: news

Amendments to Serious Shortage Protocols for fluoxetine 40mg capsules (England)
The Serious Shortage Protocols (SSP) for fluoxetine 40mg capsules ... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 8, 2019 Category: Drugs & Pharmacology Source Type: news